{"id":4590,"date":"2023-07-12T14:07:16","date_gmt":"2023-07-12T18:07:16","guid":{"rendered":"https:\/\/neoaptamers.com\/?p=4590"},"modified":"2026-04-14T10:45:01","modified_gmt":"2026-04-14T14:45:01","slug":"unlocking-therapeutic-potential-aptamers-as-tools-in-medicine","status":"publish","type":"post","link":"https:\/\/neoaptamers.com\/es\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\/","title":{"rendered":"Unlocking Therapeutic Potential: Aptamers as Tools in Medicine"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">In recent years, the field of therapeutics has witnessed remarkable advancements in the development of novel treatment strategies. Among the emerging approaches, aptamers have emerged as powerful tools with immense potential in various therapeutic applications. Aptamers, short single-stranded nucleic acid or peptide molecules, can specifically bind to a wide range of targets, including proteins, small molecules, and even cells. This unique property makes aptamers an attractive alternative to traditional therapeutics. In this blog, we delve into the potential use of aptamers in therapeutics and explore their applications across different medical domains.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">\u00bfQu\u00e9 son los Apt\u00e1meros?\u00a0<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Aptamers are short, synthetic oligonucleotide or peptide sequences that adopt specific three-dimensional structures, allowing them to bind with high affinity and specificity to their target molecules. These target molecules can include proteins, enzymes, receptors, and even whole cells. The selection and design process of aptamers involves systematic screening from large libraries to identify sequences that exhibit the desired binding properties. Aptamers have advantages over their other biological counterparts including high specificity and affinity, versality, reduced immunogenicity, and easy chemical modification.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Applications of Aptamers in Therapeutics:<\/span><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Targeted drug delivery: By conjugating aptamers to therapeutic molecules or nanoparticles, aptamers can facilitate targeted delivery to specific cells or tissues, reducing off-target effects and enhancing therapeutic efficacy (<\/span><span style=\"font-weight: 400;\">1)<\/span><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Diagnostics: Aptamers can be utilized as diagnostic probes to detect disease-specific biomarkers, enabling early disease detection and monitoring of disease progression (<\/span><span style=\"font-weight: 400;\">2)<\/span><span style=\"font-weight: 400;\">. You can read more about the advances in the use of aptamers in biosensors here: https:\/\/neoaptamers.com\/what-are-aptamer-based-biosensors-their-applications\/\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Anticoagulant therapy: Aptamers targeting coagulation factors have been developed as anticoagulant agents, providing an alternative to traditional anticoagulant drugs with improved safety profiles (<\/span><span style=\"font-weight: 400;\">3)<\/span><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Cancer therapeutics: Aptamers can be designed to specifically bind to cancer cells or tumor-associated antigens, enabling targeted drug delivery, tumor imaging, and inhibition of cancer cell proliferation (4)<\/span><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">Antiviral agents: Aptamers targeting viral proteins or viral entry receptors have shown promise as antiviral agents, inhibiting viral replication and preventing viral entry into host cells (5).<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Antibacterial agents: Aptamers can be developed to target and neutralize bacterial toxins or inhibit essential bacterial proteins, offering potential alternatives to traditional antibiotics (6)<\/span><span style=\"font-weight: 400;\">.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Traditional aptamer selection methods have faced limitations in achieving commercial success as therapeutic agents, primarily due to the challenge of fully accounting for weak binding to off-target molecules. While aptamers exhibit high specificity and affinity for their intended targets, they can also exhibit non-specific binding to unintended off-targets, which can lead to undesirable effects and compromise their therapeutic potential. This limitation has hindered the translation of aptamers into clinical applications. However, NeoVentures has introduced a groundbreaking solution, Neomers. Neomers represents the next generation of aptamer selection, employing a closed, reproducible methodology that ensures the absence of binding to off-target molecules. By implementing a stringent selection process, NeoVentures aims to address the challenge of off-target binding, enhancing the specificity and safety of aptamers for therapeutic purposes. This innovative approach has the potential to revolutionize the field of aptamer therapeutics and propel the development of targeted and precise treatments for a wide range of diseases.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Aptamers hold tremendous promise as versatile and potent tools in the field of therapeutics. Their high specificity, ease of chemical modification, and reduced immunogenicity make them attractive candidates for targeted drug delivery, diagnostics, and treatment of various diseases. As research in aptamer technology continues to advance, we can expect to witness an increasing number of aptamer-based therapeutics entering clinical practice, revolutionizing the way we approach disease treatment and patient care.\u00a0<\/span><\/p>\n<p>Learn more by getting in touch with our team today.\u00a0<a href=\"https:\/\/neoaptamers.com\/es\/contact-us\/\">Contact us on our website now.<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">1.<\/span><span style=\"font-weight: 400;\">Zhou, J., Rossi, J. J. (2017). Aptamers as targeted therapeutics: current potential and challenges. Nature Reviews Drug Discovery, 16(3), 181-202.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">2.<\/span><span style=\"font-weight: 400;\">Song, S., Wang, L., Li, J., et al. (2018). Aptamer-based biosensors. Trends in Analytical Chemistry, 100, 53-66.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">3.<\/span><span style=\"font-weight: 400;\">Toulm\u00e9, J. J. (2015). Anticoagulant aptamers: recent advances and perspectives in cardiovascular diseases. Future Medicinal Chemistry, 7(7), 897-913.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">4.<\/span><span style=\"font-weight: 400;\">Ferreira, C. S. M., Matthews, C. S., Missailidis, S. (2016). DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers. Tumor Biology, 37(1), 4227-4235.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">5.<\/span><span style=\"font-weight: 400;\">Zamecnik, P. C., Vacek, E. P., Cha, P., et al. (2020). FDA-approved antisense oligonucleotide-based therapies. Experimental and Molecular Pathology, 116, 104495.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">6.<\/span><span style=\"font-weight: 400;\">Tang, Z., Shangguan, D., Wang, K., et al. (2007). Selection of aptamers for molecular recognition and characterization of cancer cells. Analytical Chemistry, 79(13), 4900-4907.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>In recent years, the field of therapeutics has witnessed remarkable advancements in the development of novel treatment strategies. Among the emerging approaches, aptamers have emerged as powerful tools with immense potential in various therapeutic applications. Aptamers, short single-stranded nucleic acid or peptide molecules, can specifically bind to a wide range of targets, including proteins, small&hellip;&nbsp;<a href=\"https:\/\/neoaptamers.com\/es\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\/\" rel=\"bookmark\">Leer m\u00e1s &raquo;<span class=\"screen-reader-text\">Unlocking Therapeutic Potential: Aptamers as Tools in Medicine<\/span><\/a><\/p>","protected":false},"author":2,"featured_media":4755,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[8,11,18],"tags":[],"class_list":["post-4590","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aptamers","category-aptamers-in-diagnostics","category-neomers"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Unlocking Therapeutic Potential: Aptamers as Tools in Medicine<\/title>\n<meta name=\"description\" content=\"Explore the reasons why aptamers are a promising tool in medicine and there therapeutic potential. Read more today.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neoaptamers.com\/es\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Unlocking Therapeutic Potential: Aptamers as Tools in Medicine\" \/>\n<meta property=\"og:description\" content=\"Explore the reasons why aptamers are a promising tool in medicine and there therapeutic potential. Read more today.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neoaptamers.com\/es\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\/\" \/>\n<meta property=\"og:site_name\" content=\"neoaptamers\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-12T18:07:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-14T14:45:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Screenshot-2023-07-31-115827.png\" \/>\n\t<meta property=\"og:image:width\" content=\"285\" \/>\n\t<meta property=\"og:image:height\" content=\"289\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Gregory Penner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gregory Penner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\\\/\"},\"author\":{\"name\":\"Gregory Penner\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\"},\"headline\":\"Unlocking Therapeutic Potential: Aptamers as Tools in Medicine\",\"datePublished\":\"2023-07-12T18:07:16+00:00\",\"dateModified\":\"2026-04-14T14:45:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\\\/\"},\"wordCount\":712,\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Screenshot-2023-07-31-115827.png\",\"articleSection\":[\"Aptamers\",\"Aptamers in Diagnostics\",\"Neomer\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\\\/\",\"name\":\"Unlocking Therapeutic Potential: Aptamers as Tools in Medicine\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Screenshot-2023-07-31-115827.png\",\"datePublished\":\"2023-07-12T18:07:16+00:00\",\"dateModified\":\"2026-04-14T14:45:01+00:00\",\"description\":\"Explore the reasons why aptamers are a promising tool in medicine and there therapeutic potential. Read more today.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neoaptamers.com\\\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Screenshot-2023-07-31-115827.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Screenshot-2023-07-31-115827.png\",\"width\":285,\"height\":289},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neoaptamers.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Unlocking Therapeutic Potential: Aptamers as Tools in Medicine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"name\":\"Neoaptamers.com\",\"description\":\"Neoventures Biotechnology Inc.\",\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neoaptamers.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\",\"name\":\"NeoVentures Biotechnology Inc.\",\"alternateName\":\"NVB\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"width\":500,\"height\":500,\"caption\":\"NeoVentures Biotechnology Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/neoventures-biotechnology-inc-\\\/\",\"https:\\\/\\\/www.reddit.com\\\/user\\\/NeoVenturesBiotech\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@neoaptamers7964\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\",\"name\":\"Gregory Penner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"caption\":\"Gregory Penner\"},\"description\":\"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Unlocking Therapeutic Potential: Aptamers as Tools in Medicine","description":"Explore the reasons why aptamers are a promising tool in medicine and there therapeutic potential. Read more today.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neoaptamers.com\/es\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\/","og_locale":"es_ES","og_type":"article","og_title":"Unlocking Therapeutic Potential: Aptamers as Tools in Medicine","og_description":"Explore the reasons why aptamers are a promising tool in medicine and there therapeutic potential. Read more today.","og_url":"https:\/\/neoaptamers.com\/es\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\/","og_site_name":"neoaptamers","article_published_time":"2023-07-12T18:07:16+00:00","article_modified_time":"2026-04-14T14:45:01+00:00","og_image":[{"width":285,"height":289,"url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Screenshot-2023-07-31-115827.png","type":"image\/png"}],"author":"Gregory Penner","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Gregory Penner","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neoaptamers.com\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\/#article","isPartOf":{"@id":"https:\/\/neoaptamers.com\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\/"},"author":{"name":"Gregory Penner","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad"},"headline":"Unlocking Therapeutic Potential: Aptamers as Tools in Medicine","datePublished":"2023-07-12T18:07:16+00:00","dateModified":"2026-04-14T14:45:01+00:00","mainEntityOfPage":{"@id":"https:\/\/neoaptamers.com\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\/"},"wordCount":712,"publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"image":{"@id":"https:\/\/neoaptamers.com\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Screenshot-2023-07-31-115827.png","articleSection":["Aptamers","Aptamers in Diagnostics","Neomer"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/neoaptamers.com\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\/","url":"https:\/\/neoaptamers.com\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\/","name":"Unlocking Therapeutic Potential: Aptamers as Tools in Medicine","isPartOf":{"@id":"https:\/\/neoaptamers.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neoaptamers.com\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\/#primaryimage"},"image":{"@id":"https:\/\/neoaptamers.com\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Screenshot-2023-07-31-115827.png","datePublished":"2023-07-12T18:07:16+00:00","dateModified":"2026-04-14T14:45:01+00:00","description":"Explore the reasons why aptamers are a promising tool in medicine and there therapeutic potential. Read more today.","breadcrumb":{"@id":"https:\/\/neoaptamers.com\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neoaptamers.com\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/neoaptamers.com\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\/#primaryimage","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Screenshot-2023-07-31-115827.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Screenshot-2023-07-31-115827.png","width":285,"height":289},{"@type":"BreadcrumbList","@id":"https:\/\/neoaptamers.com\/unlocking-therapeutic-potential-aptamers-as-tools-in-medicine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neoaptamers.com\/"},{"@type":"ListItem","position":2,"name":"Unlocking Therapeutic Potential: Aptamers as Tools in Medicine"}]},{"@type":"WebSite","@id":"https:\/\/neoaptamers.com\/#website","url":"https:\/\/neoaptamers.com\/","name":"Neoaptamers.com","description":"Neoventures Biotechnology Inc.","publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neoaptamers.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/neoaptamers.com\/#organization","name":"NeoVentures Biotechnology Inc.","alternateName":"NVB","url":"https:\/\/neoaptamers.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","width":500,"height":500,"caption":"NeoVentures Biotechnology Inc."},"image":{"@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/neoventures-biotechnology-inc-\/","https:\/\/www.reddit.com\/user\/NeoVenturesBiotech\/","https:\/\/www.youtube.com\/@neoaptamers7964"]},{"@type":"Person","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad","name":"Gregory Penner","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","caption":"Gregory Penner"},"description":"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team."}]}},"_links":{"self":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts\/4590","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/comments?post=4590"}],"version-history":[{"count":5,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts\/4590\/revisions"}],"predecessor-version":[{"id":6587,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts\/4590\/revisions\/6587"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/media\/4755"}],"wp:attachment":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/media?parent=4590"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/categories?post=4590"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/tags?post=4590"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}